AU731018B2 - New N-aryl piperidine compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New N-aryl piperidine compounds, a process for their preparation and pharmaceutical compositions containing them Download PDF

Info

Publication number
AU731018B2
AU731018B2 AU59677/98A AU5967798A AU731018B2 AU 731018 B2 AU731018 B2 AU 731018B2 AU 59677/98 A AU59677/98 A AU 59677/98A AU 5967798 A AU5967798 A AU 5967798A AU 731018 B2 AU731018 B2 AU 731018B2
Authority
AU
Australia
Prior art keywords
dihydro
benzodioxin
amine
piperid
fumarate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59677/98A
Other languages
English (en)
Other versions
AU5967798A (en
Inventor
Valerie Audinot
Alain Gobert
Bertrand Goument
Mark Millan
Jean-Louis Peglion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of AU5967798A publication Critical patent/AU5967798A/en
Application granted granted Critical
Publication of AU731018B2 publication Critical patent/AU731018B2/en
Assigned to LES LABORATOIRES SERVIER reassignment LES LABORATOIRES SERVIER Assignment by Patentee under S 187, Reg 19.1 Assignors: ADIR ET COMPAGNIE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU59677/98A 1997-03-27 1998-03-27 New N-aryl piperidine compounds, a process for their preparation and pharmaceutical compositions containing them Ceased AU731018B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9703760 1997-03-27
FR9703760A FR2761358B1 (fr) 1997-03-27 1997-03-27 Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
AU5967798A AU5967798A (en) 1998-10-01
AU731018B2 true AU731018B2 (en) 2001-03-22

Family

ID=9505236

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59677/98A Ceased AU731018B2 (en) 1997-03-27 1998-03-27 New N-aryl piperidine compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US5965575A (enExample)
EP (1) EP0867436B1 (enExample)
JP (1) JPH10279578A (enExample)
CN (1) CN1090628C (enExample)
AT (1) ATE268767T1 (enExample)
AU (1) AU731018B2 (enExample)
BR (1) BR9803295A (enExample)
CA (1) CA2232116C (enExample)
DE (1) DE69824332T2 (enExample)
DK (1) DK0867436T3 (enExample)
ES (1) ES2223110T3 (enExample)
FR (1) FR2761358B1 (enExample)
NO (1) NO314628B1 (enExample)
NZ (1) NZ330041A (enExample)
PL (1) PL194118B1 (enExample)
PT (1) PT867436E (enExample)
ZA (1) ZA982607B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782515B1 (fr) * 1998-08-21 2000-09-22 Adir NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
EP1146871A4 (en) * 1999-01-28 2002-04-17 Bristol Myers Squibb Co HETEROCYCLIC ANTIDEPRESSANT COMPOUNDS
PT1189900E (pt) * 1999-06-30 2004-05-31 Bristol Myers Squibb Co Derivados de aminopirrolidina heterociclicos utilizados como agentes melatonergicos
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
CA2434015A1 (en) * 2001-01-16 2002-07-18 Astrazeneca Ab Therapeutic chroman compounds
NZ535574A (en) 2001-01-16 2006-07-28 Astrazeneca Ab Therapeutic heterocyclic compounds
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
WO2002069973A1 (en) * 2001-03-02 2002-09-12 Sepracor, Inc. Piperidine-piperazine ligand for neurotransmitter receptors
SE0103836D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
MXPA05013553A (es) * 2003-06-30 2006-03-09 Altana Pharma Ag Pirrolodihidroisoquinolinas como inhibidores de pde10.
EP1641457B1 (en) * 2003-06-30 2009-08-05 Nycomed GmbH Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
US7365215B2 (en) * 2003-07-14 2008-04-29 Ube Industries, Ltd. Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
US20060085924A1 (en) * 2004-10-13 2006-04-27 Gaelle Brun Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer
AU2006205797A1 (en) * 2005-01-12 2006-07-20 4Sc Ag Pyrrolodihydroisoquinolines as antiproliferative agents
DE602006006544D1 (de) * 2005-01-12 2009-06-10 Nycomed Gmbh Neue pyrrolodihydroisochinoline als pde10-inhibitoren
US8599822B2 (en) * 2005-03-23 2013-12-03 Cisco Technology, Inc. Slot-based transmission synchronization mechanism in wireless mesh networks
FR2884251B1 (fr) * 2005-04-08 2007-07-13 Servier Lab Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
US8604031B2 (en) 2006-05-18 2013-12-10 Mannkind Corporation Intracellular kinase inhibitors
RU2460727C2 (ru) 2007-03-22 2012-09-10 Астразенека Аб Хинолиновые производные для лечения воспалительных заболеваний
PE20091036A1 (es) 2007-11-30 2009-08-15 Astrazeneca Ab Derivado de quinolina como antagonista del receptor p2x7
TW200944523A (en) * 2008-02-08 2009-11-01 Organon Nv (Dihydro)pyrrolo[2,1-a]isoquinolines
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CA2232116C (fr) 2003-09-16
DK0867436T3 (da) 2004-10-04
AU5967798A (en) 1998-10-01
FR2761358B1 (fr) 1999-05-07
BR9803295A (pt) 2000-03-21
HK1014954A1 (en) 1999-10-08
NO981415D0 (no) 1998-03-27
JPH10279578A (ja) 1998-10-20
DE69824332D1 (de) 2004-07-15
NO314628B1 (no) 2003-04-22
PL194118B1 (pl) 2007-04-30
ATE268767T1 (de) 2004-06-15
CA2232116A1 (fr) 1998-09-27
DE69824332T2 (de) 2005-06-16
CN1090628C (zh) 2002-09-11
US5965575A (en) 1999-10-12
NO981415L (no) 1998-09-28
NZ330041A (en) 1999-01-28
EP0867436A1 (fr) 1998-09-30
EP0867436B1 (fr) 2004-06-09
PL325575A1 (en) 1998-09-28
PT867436E (pt) 2004-09-30
FR2761358A1 (fr) 1998-10-02
CN1197072A (zh) 1998-10-28
ZA982607B (en) 1998-09-30
ES2223110T3 (es) 2005-02-16

Similar Documents

Publication Publication Date Title
US5965575A (en) N-aryl piperidine compounds as 5HT1B antagonists
KR101663635B1 (ko) 크로몬 유도체, 그 제조방법 및 그들의 치료 분야
NZ286698A (en) Piperazine, piperidine and 1,2,5,6-tetrahydropyridine derivatives, and pharmaceutical compositions
US6391891B1 (en) Bicyclic compounds as ligands for 5-HT1 receptors
CZ286503B6 (en) Derivatives of 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine with 5-HT1A-antagonistic activity, process of their preparation and preparations in which those compounds are comprised as active components
KR20010024077A (ko) 치환된 크로만 유도체
Khorana et al. γ-Carbolines: binding at 5-HT5A serotonin receptors
DE69111915T2 (de) Pyrido(2,3-f)(1,4)thiazepine und Pyrido(3,2-b)(1,5)benzothiazepine.
EP0650964A1 (en) 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
AU725756B2 (en) New 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them
BR112013007073B1 (pt) Derivados do cromeno; composição farmacêutica; utilização de um composto da fórmula i e processo de preparação de um composto da fórmula i
US6153625A (en) Indan-1-ol compounds
Takada et al. Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors
AU736710B2 (en) New indanol compounds, a process for their preparation and pharmaceutical compositions containing them
ES2226726T3 (es) Tetrahidroquinazolina-2,4-diona y usos terapeuticos de la misma.
CN113912601B (zh) 一类新的咪唑并[1,2-a]吡啶类衍生物、其制备方法及医药用途
McQuaid et al. Substituted 5-amino-4, 5, 6, 7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity
JPH03163068A (ja) カルボン酸アミド化合物
JPH0733744A (ja) インダゾール誘導体およびその塩
Tanaka et al. Synthesis and evaluation of novel 2-aryl-2, 5, 6, 7-tetrahydro-3H-thieno [2′, 3′: 6, 7] cyclohepta [1, 2-c] pyridazin-3-ones and 2-aryl-5, 6-dihydrothieno [2, 3-h] cinnolin-3 (2H)-ones as anxiolytics
MXPA06014473A (es) Piridil piperazinas para el tratamiento de trastornos de sistema nervioso central.
Butin et al. Furan ring opening-pyridine ring closure: New Route to quinolines under the Bischler-Napieralski reaction conditions
KR100753905B1 (ko) Ｎ-치환된-1ｈ-퀴놀린-2,4-디온 화합물, 이의 제조 방법 및이를 포함하는 약학적 조성물
JP2009514795A (ja) Ｎ−置換−１ｈ−キノリン−２，４−ジオン化合物、その製造方法及びそれを含む薬学的組成物
PL240473B1 (pl) N-6(4-arylopiperazyn-1-ylo)heksylowe pochodne cyklicznych 1,8-naftylo / tetrahydrochinolino imidów / amidów / sulfonamidów oraz sposób ich otrzymywania

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: LES LABORATOIRES SERVIER

Free format text: FORMER OWNER WAS: ADIR ET COMPAGNIE